文献速递心外重症与机械循环支持

儿童耐久性心室辅助装置因心肌功能恢复而撤除:ACTION登记报告

Explantation of durable ventricular assist device for myocardial functional recovery in children: A report from the ACTION registry.
PubMed 文献 · J Heart Lung Transplant · 2026-06-15

该研究基于ACTION登记数据,分析2012年3月至2023年8月间儿童耐久性VAD因心肌功能恢复而撤除的特征与结局。938例中31例(3.3%)撤除,中位支持111天,撤除后72%无需再植入VAD或心脏移植存活。

要点

  • 儿童耐久性VAD因心肌功能恢复撤除罕见,938例中仅31例(3.3%)。
  • 撤除后中位随访2年,72%(21/29)存活且无需再植入VAD或心脏移植。
  • 撤除后10%再植入VAD、14%心脏移植、3.4%死亡。

核心结论

  • 儿童耐久性VAD因心肌功能恢复而撤除虽罕见,但多数撤除后无需晚期心衰治疗,提示候选选择适当。

研究设计与样本

  • 基于ACTION登记的回溯性研究,纳入2012年3月至2023年8月间耐久性VAD(ICF和PPF)撤除病例。
  • 共938例患者中31例(3.3%)因心肌功能恢复撤除耐久性VAD,排除临时装置。

主要发现

  • 中位VAD支持时长111天(IQR 59-183),中位年龄1.17岁(IQR 0.32-10.1),中位体重8.4 kg(IQR 6-23.8)。
  • 基础诊断:扩张型心肌病/心肌炎64%(20/31),先天性心脏病10%(3/31),其他26%(8/31)。
  • 撤除后10%(3/29)再植入VAD,14%(4/29)心脏移植,3.4%(1/29)死亡。
  • 末次随访时72%(21/29)存活且无需再植入VAD或心脏移植,撤除后中位时长2年。

临床怎么用

  • 儿童耐久性VAD患者心肌功能恢复后可考虑撤除,但需严格选择候选者。
  • 撤除后仍需监测再植入VAD、心脏移植及死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Ventricular assist device (VAD) explantation following myocardial functional recovery (MFR) remains rare in both adults and children. We aim to study the characteristics and outcomes of durable VAD explantation following MFR in children from the Advanced Cardiac Therapies Improving Outcomes Network (ACTION) registry. METHODS: All explants of durable VAD, defined as intracorporeal continuous flow devices (ICF) and paracorporeal pulsatile flow devices (PPF), performed between March 2012 and August 2023 were identified within ACTION. Temporary devices were excluded. The primary outcome was VAD and heart transplant-free survival following explantation. RESULTS: A total of 31 out of 938 patients (3.3%) underwent durable VAD explantation following MFR after a median VAD support duration of 111 days (IQR 59-183). The median age was 1.17 years (IQR 0.32-10.1), and weight was 8.4 kg (IQR 6-23.8). The underlying diagnosis was dilated cardiomyopathy/myocarditis in 64% (20/31) and congenital heart disease in 10% (3/31); others (8/31) accounted for 26%. Following VAD explantation, 10% (3/29) underwent reimplantation of VAD, 14% (4/29) underwent heart transplantation, and 3.4% (1/29) died following explantation. At the last follow-up, 72% (21/29) are alive without reimplantation of a VAD or heart transplantation at a median duration post-explant of 2 years. CONCLUSIONS: Myocardial functional recovery resulting in VAD explantation remains a rare occurrence in children. However, the majority of children did not require advanced heart failure therapies after durable VAD explant, suggesting appropriate selection of candidates. Strategies to identify patients who may benefit from explantation and predictors of myocardial functional recovery after VAD are warranted.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Langanecha B, Jeewa A, Adachi I, et al. Explantation of durable ventricular assist device for myocardial functional recovery in children: A report from the ACTION registry. J Heart Lung Transplant. 2026. PMID: 42297122. doi:10.1016/j.healun.2026.06.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。